Current status and therapeutic strategy of acute acalculous cholecystitis: Japanese nationwide survey in the era of the Tokyo guidelines
Journal of Hepato-Biliary-Pancreatic Sciences · 2024-03 · 31 (3) · 162-172
DOI: 10.1002/jhbp.1401 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 28.12.2023. Verfasst von Takanori Morikawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Acalculous Cholecystitis, Cholecystitis, Acute. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Japanese Society for Abdominal Emergency Medicine.
Abstract (Originalsprache)
Purpose
This study aimed to clarify the incidence, therapeutic modality, and prognosis of acute acalculous cholecystitis and to reveal its optimal treatment strategy.
Methods
As a project study of the Japanese Society for Abdominal Emergency Medicine, we performed a questionnaire survey of demographic data and perioperative outcomes of acute acalculous cholecystitis treated between January 2018 and December 2020 from 42 institutions.
Results
In this study, 432 patients of acute acalculous cholecystitis, which accounts for 7.04% of acute cholecystitis, were collected. According to the Tokyo guidelines severity grade, 167 (38.6%), 202 (46.8%), and 63 (14.6%) cases were classified as Grade I, II, and III, respectively. A total of 11 (2.5%) patients died and myocardial infarction/congestive heart failure was the only independent risk factor for in‐hospital death. Cholecystectomy, especially the laparoscopic approach, had more preferable outcomes compared to their counterparts. The Tokyo guidelines flow charts were useful for Grade I and II severity, but in the cases with Grade III, upfront cholecystectomy could be suitable in some patients.
Conclusions
The proportions of severity grade and mortality of acute acalculous cholecystitis were found to be similar to those of acute cholecystitis, and laparoscopic cholecystectomy is recommended as an effective treatment option. (UMIN000047631).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Department of Gastroenterological Surgery, Miyagi Cancer Center, Natori, Japan.
- Department of Surgery, Tohoku Rosai Hospital, Sendai, Japan.
- Department of Surgery, Iwate Prefectural Iwai Hospital, Ichinoseki, Japan.
- Department of Gastroenterological Surgery, Iwate Prefectural Central Hospital, Morioka, Japan.
- Department of Surgery, Aizawa Hospital, Matsumoto, Japan.
ORCID-Profile: Takanori Morikawa, Yasunori Nishida, Michiaki Unno
Förderung
- the Japanese Society for Abdominal Emergency Medicine
Zitieren
APA
Morikawa, T., Akada, M., Shimizu, K., Nishida, Y., Izai, J., Kajioka, H., Miura, T., Ishida, M., & Unno, M. (2024). Current status and therapeutic strategy of acute acalculous cholecystitis: Japanese nationwide survey in the era of the Tokyo guidelines. Journal of Hepato-Biliary-Pancreatic Sciences, 31(3), 162-172. https://doi.org/10.1002/jhbp.1401
Vancouver
Morikawa T, Akada M, Shimizu K, Nishida Y, Izai J, Kajioka H, et al. Current status and therapeutic strategy of acute acalculous cholecystitis: Japanese nationwide survey in the era of the Tokyo guidelines. Journal of Hepato-Biliary-Pancreatic Sciences. 2024;31(3):162-172. doi:10.1002/jhbp.1401
BibTeX
@article{Morikawa2024,
author = {Morikawa, Takanori and Akada, Masanori and Shimizu, Kenji and Nishida, Yasunori and Izai, Junko and Kajioka, Hiroki and Miura, Takayuki and Ishida, Masaharu and Unno, Michiaki},
title = {Current status and therapeutic strategy of acute acalculous cholecystitis: Japanese nationwide survey in the era of the Tokyo guidelines},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2024},
volume = {31},
number = {3},
pages = {162--172},
doi = {10.1002/jhbp.1401}
}
EUVIMED